product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
EGF Receptor (1F4) Mouse mAb
catalog :
2239
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
1F4
reactivity :
human, mouse
application :
western blot
citations: 22
Published Application/Species/Sample/DilutionReference
  • western blot; human; 1:1000; loading ...; fig 2a
Senturk S, Shirole N, Nowak D, Corbo V, Pal D, Vaughan A, et al. Rapid and tunable method to temporally control gene editing based on conditional Cas9 stabilization. Nat Commun. 2017;8:14370 pubmed publisher
  • western blot; human; 1:1000; loading ...; fig 3c
Wang A, Cui M, Qu H, Di J, Wang Z, Xing J, et al. Induction of anti-EGFR immune response with mimotopes identified from a phage display peptide library by panitumumab. Oncotarget. 2016;7:75293-75306 pubmed publisher
  • western blot; mouse; fig 1B
Thomas J, Chhuy Hy L, Andrykovich K, Moos M. SMOC Binds to Pro-EGF, but Does Not Induce Erk Phosphorylation via the EGFR. PLoS ONE. 2016;11:e0154294 pubmed publisher
  • western blot; human
Haven B, Heilig E, Donham C, Settles M, Vasilevsky N, Owen K. Registered report: A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. elife. 2016;5: pubmed publisher
  • western blot; human; fig 6
Wilson F, Johannessen C, Piccioni F, Tamayo P, Kim J, Van Allen E, et al. A functional landscape of resistance to ALK inhibition in lung cancer. Cancer Cell. 2015;27:397-408 pubmed publisher
  • western blot; human; 1:1000
Tjin Tham Sjin R, Lee K, Walter A, Dubrovskiy A, Sheets M, Martin T, et al. In vitro and in vivo characterization of irreversible mutant-selective EGFR inhibitors that are wild-type sparing. Mol Cancer Ther. 2014;13:1468-79 pubmed publisher
Lupia M, Cavallaro U. Ovarian cancer stem cells: still an elusive entity?. Mol Cancer. 2017;16:64 pubmed publisher
Tisza M, Zhao W, Fuentes J, Prijic S, Chen X, Levental I, et al. Motility and stem cell properties induced by the epithelial-mesenchymal transition require destabilization of lipid rafts. Oncotarget. 2016;7:51553-51568 pubmed publisher
Rinkenbaugh A, Baldwin A. The NF-?B Pathway and Cancer Stem Cells. Cells. 2016;5: pubmed publisher
Kim K, Kim D, Lee S, Kim S, Noh J, Kim J, et al. Pairwise detection of site-specific receptor phosphorylations using single-molecule blotting. Nat Commun. 2016;7:11107 pubmed publisher
Papadopoulos D, Dietze R, Shihan M, Kirch U, Scheiner Bobis G. Dehydroepiandrosterone Sulfate Stimulates Expression of Blood-Testis-Barrier Proteins Claudin-3 and -5 and Tight Junction Formation via a Gnα11-Coupled Receptor in Sertoli Cells. PLoS ONE. 2016;11:e0150143 pubmed publisher
Zhu S, Chen Z, Katsha A, Hong J, Belkhiri A, el Rifai W. Regulation of CD44E by DARPP-32-dependent activation of SRp20 splicing factor in gastric tumorigenesis. Oncogene. 2016;35:1847-56 pubmed publisher
Ruan Z, Liu J, Kuang Y. Isolation and characterization of side population cells from the human ovarian cancer cell line SK-OV-3. Exp Ther Med. 2015;10:2071-2078 pubmed
Lei W, Long Y, Li S, Liu Z, Zhu F, Hou F, et al. Homocysteine Induces Collagen I Expression by Downregulating Histone Methyltransferase G9a. PLoS ONE. 2015;10:e0130421 pubmed publisher
Hernandez J, Kim J, Verdone J, Liu X, Torga G, Pienta K, et al. Alternative CD44 splicing identifies epithelial prostate cancer cells from the mesenchymal counterparts. Med Oncol. 2015;32:159 pubmed publisher
Ruibal Ã, Aguiar P, Del Río M, Nuñez M, Pubul V, Herranz M. Cell membrane CD44v6 levels in squamous cell carcinoma of the lung: association with high cellular proliferation and high concentrations of EGFR and CD44v5. Int J Mol Sci. 2015;16:4372-8 pubmed publisher
Spiesz E, Thorpe C, Chaudhry S, Riley G, Birch H, Clegg P, et al. Tendon extracellular matrix damage, degradation and inflammation in response to in vitro overload exercise. J Orthop Res. 2015;33:889-97 pubmed publisher
Tao R, Xiong X, Liangpunsakul S, Dong X. Sestrin 3 protein enhances hepatic insulin sensitivity by direct activation of the mTORC2-Akt signaling. Diabetes. 2015;64:1211-23 pubmed publisher
Pospelova T, Pospelov V. Latest progress in tyrosine kinase inhibitors. Oncotarget. 2014;5:1157-61 pubmed
Funari V, Winkler M, Brown J, Dimitrijevich S, Ljubimov A, Saghizadeh M. Differentially expressed wound healing-related microRNAs in the human diabetic cornea. PLoS ONE. 2013;8:e84425 pubmed publisher
Raynes R, Pombier K, Nguyen K, Brunquell J, Mendez J, Westerheide S. The SIRT1 modulators AROS and DBC1 regulate HSF1 activity and the heat shock response. PLoS ONE. 2013;8:e54364 pubmed publisher
Wang J, Ko C, Chen L, Wang W, Chang W. Functional role of NF-IL6beta and its sumoylation and acetylation modifications in promoter activation of cyclooxygenase 2 gene. Nucleic Acids Res. 2006;34:217-31 pubmed
product information
SKU :
2239S
Product-Name :
EGF Receptor (1F4) Mouse mAb
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H
Applications :
Western blot
Product-Category :
RTK
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
175
Host :
Mouse
Target :
EGFR
Primary-Protein :
EGFR
Alt-Names :
EGFR,ERBB,ERBB1,Epidermal growth factor receptor,HER1,PIG61,Proto-oncogene c-ErbB-1,Receptor tyrosine-protein kinase erbB-1,avian erythroblastic leukemia viral (v-erb-b) oncogene homolog,cell growth inhibiting protein 40,cell proliferation-inducing protein 61,epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian),mENA
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.